Submitted by Anonymous (not verified) on 18 September 2023 - 15:46
Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Alopecia Areata, Date of authorisation: 15/09/2023, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Alopecia Areata, Date of authorisation: 15/09/2023, Status: Authorised